Related Experiment Video
Updated: Aug 8, 2026

Generation of Fluorescent Protein Fusions in Candida Species
Published on: March 4, 2017
Candidemia in pediatric patients with congenital heart disease
Lucía García San Miguel1, Javier Cobo, Enrique Otheo
1Infectious Diseases Department, Ramon y Cajal Hospital, 28034 Madrid, Spain. lgarcias.hrc@salud.madrid.org
Insights
Candidemia, a serious bloodstream infection, is common in pediatric patients with congenital heart disease (CHD). While mortality is high, it
Area of Science:
- Pediatric Infectious Diseases
- Cardiology
Background:
- Candidemia poses a significant challenge in pediatric care.
- Congenital heart disease (CHD) patients exhibit the highest rates of candidemia in our hospital.
- Understanding candidemia's clinical and mortality features in this vulnerable population is crucial.
Purpose of the Study:
- To describe the clinical characteristics and mortality patterns of candidemia in pediatric patients with CHD.
- To identify factors associated with mortality in this cohort.
Main Methods:
- Retrospective case series analysis of 52 pediatric patients with candidemia and CHD from 1988 to 2000.
- Data collection included patient demographics, treatment, causative Candida species, and outcomes.
- Statistical analysis identified independent predictors of mortality.
Main Results:
- The study included very young infants (median age, 2 months) often receiving prolonged antibiotic therapy (median, 20.5 days).
- Candida parapsilosis was the predominant species (54%).
- In-hospital mortality was 39%, with 14% attributed to candidemia. Catheter maintenance and patient severity (Pediatric Risk Score of Mortality I) were associated with mortality.
Conclusions:
- Candidemia in pediatric CHD patients often affects very young infants and is linked to prolonged antibiotic use.
- While overall mortality is high, candidemia is not always the direct cause of death.
- Optimal management strategies include ruling out endocarditis, prompt antifungal treatment, and considering catheter removal.
Abstract:
Candidemia is an important problem in pediatrics. In our hospital, highest candidemia rates were documented among children with congenital heart disease (CHD). A series was conducted to describe the clinical and mortality features of candidemia in these patients. Fifty-two cases (1988-2000) included very young infants (median age, 2 months) who received long-term antibiotic treatment (median, 20.5 days). Candida parapsilosis predominated (54%). Endovascular infections occurred in 11.5%. In-hospital mortality was 39% and related mortality 14%. Maintenance of catheter (odds ratio [OR], 6.0; 95% confidence interval [CI], 1.0-37.2; P = .05) and severity of patients as measured with the Pediatric Risk Score of Mortality I (OR, 1.1, 95% CI, 1.0-1.3; P = .05) were independently associated with mortality. In summary, candidemia in children with CHD is diagnosed to very young infants with prolonged antibiotic therapy. Mortality is high but, in most cases, is not related to candidemia. Optimal management may include exclusion of endocarditis, early antifungal treatment, and catheter removal.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Mitral Stenosis III: Medical Management
Endocarditis I: Introduction
Endocarditis III: Medical Management
Cryptococcal Meningitis
Candidiasis

